ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Oyavas 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung - 
67857001 Spirig HealthCare AG
Oyavas 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung04.06.2021
  04.06.2021
(L01FG01) 
WHO-DDD03.06.2026
07.16.10. 
07.16.10. 
A  
Yes 
IP 
257.57Yes
    
10 %296.55
  
7680678570017Biotechnologika
  
Composition
bevacizumabum 100 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 5.42 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Bevacizumab100mg / 4ml
BAG: Active AgentDose
Bevacizumab100 mg
 
Inactive agents
Disodium Phosphate
Sodium Dihydrogenophosphate Monohydrate
Polysorbatum 20
Trehalosum Dihydricum
 
Source
Data was imported : 08.08.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home